[Medicilon: The price of experimental monkeys is rising and the supply is tight. A flexible quotation strategy has been adopted] On November 6, Medicilon (688202.SH) released an investor relations activity record announcement. As the global innovative drug research and development industry continues to recover, market demand gradually picks up, and changes in the supply and demand structure have led to an upward trend in the price of experimental monkeys since 2026, and the overall supply is tight. The company has actively adopted a number of measures such as diversifying procurement channels and deepening cooperation with experimental animal suppliers to ensure that the supply of experimental animals, especially experimental monkeys, is stable and able to meet business needs. According to market development, the company adopts a more flexible quotation strategy for experimental monkey-related business to ensure the company's profitability and sustainable development capabilities.